Pemphigus Foliaceus in Cats: In-Depth Welfare Guide
An in-depth guide to pemphigus foliaceus in cats, covering autoimmune pathology, welfare impacts, and advanced management.
Key Facts
Pemphigus foliaceus is the most common autoimmune skin disease of cats
Autoantibodies target desmoglein-1, a protein holding skin cells together
Pustules and crusts develop on the face, ears, and feet in characteristic patterns
The condition causes significant pain and discomfort, particularly on paw pads
Corticosteroids remain the cornerstone of treatment with additional immunosuppressants
Some cases may be drug-induced (antibiotics, antifungals) requiring drug withdrawal
Welfare Considerations and Management
In-depth welfare management of feline pemphigus foliaceus requires sustained immunosuppression tailored to individual response. Chlorambucil is the preferred steroid-sparing agent in cats (less hepatotoxic than azathioprine). Ciclosporin provides effective immunosuppression with good tolerability. Drug-induced cases (check medication history) may resolve after drug withdrawal. Pain management, particularly for footpad involvement, is often underappreciated. Regular monitoring for treatment side effects and disease activity guides long-term management.
What You Can Do
Ensure adequate pain management, especially for paw pad involvement
Review medication history for potential drug-induced cases before starting immunosuppression
Use chlorambucil rather than azathioprine as the steroid-sparing agent in cats
Monitor regularly for treatment side effects and signs of disease relapse